Impact on Research

Finding Cures Starts Here

The Lymphoma Research Foundation (LRF) is committed to funding the most promising lymphoma researchers and advancing the understanding of the more than 100 different subtypes of lymphoma.  LRF’s disease-specificity and hyper-focus on finding cures for every type of lymphoma ensure the next generation of cancer researchers dedicate their careers to studying lymphoma, and world-leading lymphoma experts collaborate and accelerate the pace of scientific discovery.


The LRF Scientific Advisory Board (SAB) is comprised of 45 world-renowned lymphoma experts, who seek out the most innovative and promising lymphoma research projects to support.


LRF remains dedicated to finding cures for lymphoma through an aggressively-funded program for researchers.


LRF global lymphoma consortia, research initiatives, and scientific workshops help to mobilize the research community, overcome systemic challenges and speed the progress by which new treatments are developed.


Investing in the Best and Brightest Researchers, Achieving Breakthroughs

LRF funds the very best science that has the greatest potential to impact patients and ensures the best and brightest researchers remain in the field.
To date, LRF has funded more than $72 million in lymphoma-specific research and has supported key breakthroughs including:

First In-Human Clinical Trial of Adoptive Immunotherapy in Follicular Lymphoma

First Publication of the Whole-Genome Sequencing of Mantle Cell Lymphoma

Identifying the Role RNA Splicing Plays in Chronic Lymphocytic Leukemia

Using Micro RNA Array to Identify Biomarkers that Play a Critical Role in Mantle Cell Lymphoma Drug Resistance and Progression

Identifying the Mechanism Behind Ibrutinib Resistance in Mantle Cell Lymphoma

“LRF had a profound impact at the beginning of my academic career, when I needed the support most. I will always be grateful to LRF for its continuous investment in supporting innovative science, clinical research and educational programs.” – Dr. Eduardo Sotomayor, LRF Scientific Advisory Board Member

Meet Our 2023 Researchers

Roni Shouval, MD, PhD
Memorial Sloan Kettering Cancer Center
Clinical Career Development Award

Xiaolong (Alan) Zhou, MD
Northwestern University Feinberg School of Medicine
Clinical Career Development Award

Elise Chong, MD
University of Pennsylvania, Perelman School of Medicine
Clinical Career Development Award, Health Equity Initiative

Patrizia Mondello, MD, PhD
Mayo Clinic, Rochester
Clinical Career Development Award

Tayla Heavican-Foral, PhD
Dana-Farber Cancer Institute
Postdoctoral Fellowship Grant, Dr. Oliver Press Memorial Fellow, Health Equity Initiative

Sanket Shah, PhD
Weill Medical College of Cornell University
Postdoctoral Fellowship Grant, Dr. Bruce D. Cheson Fellow

Anouchka Laurent, PhD
Columbia University in the City of New York
Postdoctoral Fellowship Grant

Yifei Liao, PhD
Brigham and Women’s Hospital
Postdoctoral Fellowship Grant

Christopher Sauter, MD
University of Pennsylvania, Perelman School of Medicine
Postdoctoral Fellowship Grant

Ajlan Al Zaki, MD, PhD
The University of Texas, M.D. Anderson Cancer Center
Postdoctoral Fellowship Grant

Edward Dominguez, PhD
Beckman Research Institute City of Hope
Postdoctoral Fellowship Grant, Health Equity Initiative

Joshua Brody, MD
Icahn School of Medicine at Mount Sinai
Jaime Peykoff Follicular Lymphoma Priority Research Grant

Matthew Maurer, D.M.Sc
Mayo Clinic, Rochester
Jaime Peykoff Follicular Lymphoma Priority Research Grant

Wendy Béguelin, PhD
Weill Medical College of Cornell University
Jaime Peykoff Follicular Lymphoma Priority Research Grant

Arash Alizadeh, MD, PhD
Stanford University
Jaime Peykoff Follicular Lymphoma Priority Research Grant

Robert Kridel, MD, MPH, PhD
University Health Network, Toronto Jaime Peykoff Follicular Lymphoma Priority Research Grant


25 Years of Innovation & Progress

1995 was a significant year for the Lymphoma Research Foundation (LRF)—it was then that LRF realized its dual mission to eradicate lymphoma and to serve those touched by this disease.

Finding cures starts here.  Through lymphoma-specific research grants and consortia, LRF-supported researchers have been involved in many of the most significant lymphoma breakthroughs witnessed in the past quarter-century.